MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1001.05%
Quick Ratio
1001.05%
Cash Ratio
244.61%
Debt to Asset Ratio
10.67%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
49,629
58,223
76,957
93,414
Short-term investments
148,831
-
-
-
Prepaid expenses and other current assets
4,643
6,887
3,632
1,998
Total current assets
203,103
65,110
80,589
95,412
Property and equipment, at cost
241
241
241
241
Less accumulated depreciation
151
131
112
93
Property and equipment, net
90
110
129
148
Other assets
2,550
2,003
2,061
1,529
Total assets
205,743
67,223
82,779
97,089
Accounts payable
14,010
13,084
9,989
5,491
Accrued liabilities
6,279
10,563
10,762
7,501
Total current liabilities
20,289
23,647
20,751
12,992
Income tax payable
-
-
1,037
-
Other liabilities
1,660
1,476
-
-
Total liabilities
21,949
25,123
21,788
-
Common stock, 0.001 par value 200,000,000 shares authorized as of june 30, 2026 (unaudited) and december 31, 2025 20,482,400 and 12,948,308 shares issued and outstanding as of june 30, 2026 (unaudited) and december 31, 2025, respectively
21
14
13
13
Additional paid-in capital
452,667
287,599
284,348
282,675
Accumulated other comprehensive (loss) income
-54
-4
3
-6
Accumulated deficit
-268,840
-245,509
-223,373
-198,585
Total stockholders equity
183,794
42,100
60,991
84,097
Total liabilities and stockholders' equity
205,743
67,223
82,779
97,089
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$148,831K Cash and cashequivalents$49,629K (-53.24%↓ Y/Y)Prepaid expenses andother current assets$4,643K (215.42%↑ Y/Y)Property and equipment,at cost$241K (29.57%↑ Y/Y)Total current assets$203,103K (88.73%↑ Y/Y)Other assets$2,550K (4373.68%↑ Y/Y)Property and equipment,net$90K (-18.18%↓ Y/Y)Less accumulateddepreciation$151K (98.68%↑ Y/Y)Total assets$205,743K (90.89%↑ Y/Y)Total liabilities andstockholders' equity$205,743K (90.89%↑ Y/Y)Total stockholdersequity$183,794K (86.38%↑ Y/Y)Total liabilities$21,949K Accumulated deficit-$268,840K (-48.61%↓ Y/Y)Accumulated othercomprehensive (loss) income-$54K Additional paid-in capital$452,667K (61.95%↑ Y/Y)Total currentliabilities$20,289K (121.25%↑ Y/Y)Other liabilities$1,660K Common stock, 0.001 parvalue 200,000,000...$21K (75.00%↑ Y/Y)Accounts payable$14,010K (164.29%↑ Y/Y)Accrued liabilities$6,279K (62.29%↑ Y/Y)

Forte Biosciences, Inc. (FBRX)

Forte Biosciences, Inc. (FBRX)